Developed and developing country governments around the world often struggle to provide prompt and affordable access to medicines for the populace and so maintain proper levels of health care at affordable prices.
This collection explores the complexities associated with the intersection of pharmaceutical law and policy and public health. Focusing on patent and relevant regulatory laws, the collection provides a comprehensive overview of the most important and pressing issues governments are currently facing in regards to ensuring access to medicines at an affordable cost. Each chapter focuses on a separate issue and offers clear, balanced and detailed analysis of the international framework, trends and available policy options.
Throughout, the volume emphasises the need for governments to think and act in a systemic manner and break away from the ‘silo’ method of dividing responsibilities between various government departments.
The book sets out ways in which law and policy in the area of pharmaceutical patents, health and policy can be integrated in order to ensure coherence and regulatory predictability.
